Zomedica Corp.
—- Market cap
- —
- Debt
- +$4.36M
- Cash
- −$9.02M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ZOM stock price vs QRVO: inconclusive — current versus $0.08 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at QRVO's multiple
Implied fair value · at ZOM's multiple
Needs ZOM P/S.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ZOM FY 2025 (ended Dec 31, 2025) · QRVO FY 2026 (ended Mar 28, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 85% equity / 15% debt · EV / Revenue 2.55x · EV / EBITDA 11.63x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Zomedica Corp. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Qorvo, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.04x
0.46x
Net debt / EBITDA
Leverage against operating earnings
0.06x
0.41x
Cash and equivalents
Liquid reserves on the balance sheet
$9.02M
$1.22B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Zoetis Inc.
ZOM vs ZTS
Elanco Animal Health Inc
ZOM vs ELAN
PHIBRO ANIMAL HEALTH CORP
ZOM vs PAHC
SKYWORKS SOLUTIONS, INC.
ZOM vs SWKS
Broadcom Inc.
ZOM vs AVGO
Marvell Technology, Inc.
ZOM vs MRVL
ON SEMICONDUCTOR CORP
ZOM vs ON
NXP Semiconductors N.V.
ZOM vs NXPI
TEXAS INSTRUMENTS INC
ZOM vs TXN
$4.36M
$1.55B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.